Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease - PubMed (original) (raw)
Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease
William M McClellan et al. J Am Soc Nephrol. 2004 Jul.
Abstract
The risk of progression to ESRD among individuals with cardiovascular disease and chronic kidney disease (CKD) is not well defined. The purpose of this study was to describe the risk of ESRD among patients with cardiovascular disease. Charts were abstracted for randomly selected hospitalized Medicare beneficiaries with a diagnosis of either congestive heart failure (CHF) or acute myocardial infarction (AMI). The prevalence of CKD, based on the estimated modified diet in renal disease GFR of <60 ml/min per m2, was 60.4% of CHF patients and 51.7% of AMI patients. When compared with patients without CKD, the 30-d readmission rate was higher for CHF patients with CKD (odds ratio [OR], 1.70; 95% confidence interval [CI], 1.18 to 2.44) and for AMI patients with CKD (OR, 1.78; 95% CI, 1.17 to 2.70). CHF patients (OR, 1.62; 95% CI, 1.15 to 2.30) and AMI patients (OR, 3.10; 95% CI, 1.98 to 4.84) with CKD were more likely to die during the year after discharge from the hospital. ESRD after discharge occurred in nine of 517 patients with AMI and 24 of 640 patients with CHF. CKD increased the risk of ESRD among CHF patients (OR, 34.5; 95% CI, 4.23 to 279.43) and AMI patients (0 and 3% for those without and with CKD, respectively). At discharge, 18% of AMI patients and 21% of CHF patients with CKD were discharged with a diagnosis of renal disease. CKD is highly prevalent among patients with cardiovascular disease and is associated with increased risk of adverse outcomes, including progression to ESRD. This study suggests that opportunities may exist to improve the detection of CKD in these patients who are hospitalized with cardiovascular disease.
Similar articles
- Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR.
Massicotte-Azarniouch D, Kuwornu JP, Carrero JJ, Lam NN, Molnar AO, Zimmerman D, McCallum MK, Garg AX, Sood MM. Massicotte-Azarniouch D, et al. Am J Kidney Dis. 2018 Feb;71(2):191-199. doi: 10.1053/j.ajkd.2017.08.016. Epub 2017 Nov 16. Am J Kidney Dis. 2018. PMID: 29153994 - Thiazide and thiazide-like diuretics are associated with improved cardiovascular and renal outcomes in patients with chronic kidney disease.
Lin HY, Chang YH, Wang YT, Liang PI, Hung CC, Chang JM, Dai DF, Lin CS, Chang KT. Lin HY, et al. Ann Acad Med Singap. 2023 Oct 30;52(10):510-521. doi: 10.47102/annals-acadmedsg.202359. Ann Acad Med Singap. 2023. PMID: 38920202 - Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis.
Levin A. Levin A. Semin Dial. 2003 Mar-Apr;16(2):101-5. doi: 10.1046/j.1525-139x.2003.16025.x. Semin Dial. 2003. PMID: 12641872 Review. - Magnitude of rate of change in kidney function and future risk of cardiovascular events.
Turin TC, Jun M, James MT, Tonelli M, Coresh J, Manns BJ, Hemmelgarn BR. Turin TC, et al. Int J Cardiol. 2016 Jan 1;202:657-65. doi: 10.1016/j.ijcard.2015.09.090. Epub 2015 Sep 28. Int J Cardiol. 2016. PMID: 26453813 - Chronic kidney disease in Japan.
Iseki K. Iseki K. Intern Med. 2008;47(8):681-9. doi: 10.2169/internalmedicine.47.0906. Epub 2008 Apr 16. Intern Med. 2008. PMID: 18421182 Review.
Cited by
- Impact of chronic kidney disease and end-stage renal disease on the mid-term adverse outcomes in diabetic patients with cardiovascular diseases.
Chou CL, Chiu HW, Hsu YH, Yu SM, Liou TH, Sung LC. Chou CL, et al. Sci Rep. 2024 Jul 9;14(1):15770. doi: 10.1038/s41598-024-66655-0. Sci Rep. 2024. PMID: 38982230 Free PMC article. - Association between bilirubin and chronic kidney disease in hypertensive patients: The China hypertension registry study.
Zhao P, Xu H, Shi Y, Song X, Qiu G, Ding C, Zhou W, Yu C, Wang T, Zhu L, Bao H, Cheng X. Zhao P, et al. J Clin Hypertens (Greenwich). 2023 Dec;25(12):1185-1192. doi: 10.1111/jch.14727. Epub 2023 Nov 20. J Clin Hypertens (Greenwich). 2023. PMID: 37986685 Free PMC article. - Non-Diabetic Kidney Disease in Type 2 Diabetes Mellitus: A Changing Spectrum with Therapeutic Ascendancy.
Prasad N, Veeranki V, Bhadauria D, Kushwaha R, Meyyappan J, Kaul A, Patel M, Behera M, Yachha M, Agrawal V, Jain M. Prasad N, et al. J Clin Med. 2023 Feb 20;12(4):1705. doi: 10.3390/jcm12041705. J Clin Med. 2023. PMID: 36836240 Free PMC article. - Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals: A Randomized Clinical Trial.
Nadkarni GN, Fei K, Ramos MA, Hauser D, Bagiella E, Ellis SB, Sanderson S, Scott SA, Sabin T, Madden E, Cooper R, Pollak M, Calman N, Bottinger EP, Horowitz CR. Nadkarni GN, et al. JAMA Netw Open. 2022 Mar 1;5(3):e221048. doi: 10.1001/jamanetworkopen.2022.1048. JAMA Netw Open. 2022. PMID: 35244702 Free PMC article. Clinical Trial. - Chronic kidney disease: prevalence and association with handgrip strength in a cross-sectional study.
Cheng Y, Liu M, Liu Y, Xu H, Chen X, Zheng H, Wu X, Shen Z, Shen C. Cheng Y, et al. BMC Nephrol. 2021 Jul 2;22(1):246. doi: 10.1186/s12882-021-02452-5. BMC Nephrol. 2021. PMID: 34215205 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical